KR20190079213A - Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same - Google Patents
Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same Download PDFInfo
- Publication number
- KR20190079213A KR20190079213A KR1020170181261A KR20170181261A KR20190079213A KR 20190079213 A KR20190079213 A KR 20190079213A KR 1020170181261 A KR1020170181261 A KR 1020170181261A KR 20170181261 A KR20170181261 A KR 20170181261A KR 20190079213 A KR20190079213 A KR 20190079213A
- Authority
- KR
- South Korea
- Prior art keywords
- fermented
- goat
- ginseng extract
- ginseng
- ginsenoside
- Prior art date
Links
- 235000020710 ginseng extract Nutrition 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 14
- 241000208340 Araliaceae Species 0.000 claims abstract description 60
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 60
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 60
- 235000008434 ginseng Nutrition 0.000 claims abstract description 60
- 238000000855 fermentation Methods 0.000 claims abstract description 40
- 230000004151 fermentation Effects 0.000 claims abstract description 40
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 22
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 239000007787 solid Substances 0.000 claims abstract description 13
- 241000283707 Capra Species 0.000 claims description 88
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000012153 distilled water Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 241000233866 Fungi Species 0.000 claims description 3
- 235000020251 goat milk Nutrition 0.000 claims description 3
- 244000005700 microbiome Species 0.000 claims description 3
- 244000205939 Rhizopus oligosporus Species 0.000 claims description 2
- 235000000471 Rhizopus oligosporus Nutrition 0.000 claims description 2
- 240000005384 Rhizopus oryzae Species 0.000 claims description 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims description 2
- 235000021307 Triticum Nutrition 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 claims 1
- 229940089161 ginsenoside Drugs 0.000 abstract description 14
- 239000000284 extract Substances 0.000 abstract description 9
- 238000005516 engineering process Methods 0.000 abstract description 5
- 235000013376 functional food Nutrition 0.000 abstract description 2
- 238000000132 electrospray ionisation Methods 0.000 description 25
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- FBFMBWCLBGQEBU-GYMUUCMZSA-N 20-gluco-ginsenoside-Rf Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FBFMBWCLBGQEBU-GYMUUCMZSA-N 0.000 description 8
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 8
- 235000019253 formic acid Nutrition 0.000 description 8
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 8
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000003643 water by type Substances 0.000 description 6
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 description 5
- FBFMBWCLBGQEBU-RXMALORBSA-N (2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5s,6r)-2-[[(3s,5r,6s,8r,9r,10r,12r,13r,14r,17s)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2s)-6-methyl-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecah Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FBFMBWCLBGQEBU-RXMALORBSA-N 0.000 description 5
- HYPFYJBWSTXDAS-UHFFFAOYSA-N Ginsenoside Rd Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C4CCC5C(C)(C)C(CCC5(C)C4CC(O)C23C)OC6OC(CO)C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C HYPFYJBWSTXDAS-UHFFFAOYSA-N 0.000 description 5
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 description 5
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- UOJAEODBOCLNBU-UHFFFAOYSA-N vinaginsenoside R4 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O UOJAEODBOCLNBU-UHFFFAOYSA-N 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- AGBCLJAHARWNLA-DQUQINEDSA-N Ginsenoside RG2 Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@@](C)(O)CCC=C(C)C)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O AGBCLJAHARWNLA-DQUQINEDSA-N 0.000 description 4
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 4
- PFSIGTQOILYIIU-UHFFFAOYSA-N ginsenoside Rb3 Natural products CC(=CCCC(C)(O)C1CCC2(C)C3CCC4C(C)(C)C(CCC4(C)C3CC(OC5OC(COC6OCC(O)C(O)C6O)C(O)C(O)C5O)C12C)OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C PFSIGTQOILYIIU-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- ZTQSADJAYQOCDD-UHFFFAOYSA-N ginsenoside-Rd2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OCC(O)C(O)C1O ZTQSADJAYQOCDD-UHFFFAOYSA-N 0.000 description 3
- AGBCLJAHARWNLA-UHFFFAOYSA-N (20R)-ginsenoside Rg2 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C3C(C)(C)C(O)CCC3(C)C3C(C4(CCC(C4C(O)C3)C(C)(O)CCC=C(C)C)C)(C)C2)OC(CO)C(O)C1O AGBCLJAHARWNLA-UHFFFAOYSA-N 0.000 description 2
- RAQNTCRNSXYLAH-RFCGZQMISA-N (20S)-ginsenoside Rh1 Chemical compound O([C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RAQNTCRNSXYLAH-RFCGZQMISA-N 0.000 description 2
- NFZYDZXHKFHPGA-UHFFFAOYSA-N 17alpha-hydroxygofruside Natural products C12CC(C)(C)CCC2(C(=O)OC2C(C(O)C(O)C(CO)O2)O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OC(C(O)=O)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NFZYDZXHKFHPGA-UHFFFAOYSA-N 0.000 description 2
- QXQFFGOMXYKNBA-UHFFFAOYSA-N Chikusetsusaponin V Natural products CC1(C)CCC2(CCC3C(=CCC4C3(C)CCC5C(C)(C)C(CCC45C)OC6OC(C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C(=O)O)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O QXQFFGOMXYKNBA-UHFFFAOYSA-N 0.000 description 2
- NFZYDZXHKFHPGA-QQHDHSITSA-N Chikusetsusaponin-V Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NFZYDZXHKFHPGA-QQHDHSITSA-N 0.000 description 2
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 2
- UZIOUZHBUYLDHW-MSJHMJQNSA-N Ginsenoside Rf Natural products O([C@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@@H]2[C@](C)([C@@]3(C)[C@H]([C@@H](O)C2)[C@@H]([C@@](O)(CC/C=C(\C)/C)C)CC3)C1)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 UZIOUZHBUYLDHW-MSJHMJQNSA-N 0.000 description 2
- RAQNTCRNSXYLAH-UHFFFAOYSA-N Ginsenoside Rh1 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(C3)C)(C)C1C(O)CC2C1(C)CCC(O)C(C)(C)C1C3OC1OC(CO)C(O)C(O)C1O RAQNTCRNSXYLAH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- YQKCHRBAJSATCG-UHFFFAOYSA-N UNPD30744 Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC(C)(CCC=C(C)C)C2C3C(C4(CCC5C(C)(C)C(OC6C(C(O)C(O)C(CO)O6)OC6C(C(O)C(O)C(CO)O6)O)CCC5(C)C4CC3O)C)(C)CC2)O1 YQKCHRBAJSATCG-UHFFFAOYSA-N 0.000 description 2
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 2
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 2
- NODILNFGTFIURN-GZPRDHCNSA-N ginsenoside Rb2 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-GZPRDHCNSA-N 0.000 description 2
- NODILNFGTFIURN-USYOXQFSSA-N ginsenoside Rb3 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@@H](O)[C@H](O)[C@H]1O NODILNFGTFIURN-USYOXQFSSA-N 0.000 description 2
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 2
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 2
- UZIOUZHBUYLDHW-XUBRWZAZSA-N ginsenoside Rf Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H]2C(C)(C)[C@@H](O)CC[C@]2(C)[C@H]2C[C@@H](O)[C@H]3[C@@]([C@@]2(C1)C)(C)CC[C@@H]3[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZIOUZHBUYLDHW-XUBRWZAZSA-N 0.000 description 2
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- RBRANZURTULKJD-UHFFFAOYSA-N ginsenoside Ro Natural products CC1(C)CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C)(C(O)C(O)C6OC7OC(CO)C(O)C(O)C7O)C(=O)O)C(C)(C)C5CCC34C)C2C1)C(=O)OC8OC(CO)C(O)C(O)C8O RBRANZURTULKJD-UHFFFAOYSA-N 0.000 description 2
- UVBLDLGZDSGCSN-UHFFFAOYSA-N ginsenoside-Rb3 Natural products C1=CC2C3(C)CCC(O)C(C)(C)C3CCC2(C)C2(C)CCC34CCC(C)C(C)C4C21OC3=O UVBLDLGZDSGCSN-UHFFFAOYSA-N 0.000 description 2
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 2
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 2
- 238000002013 hydrophilic interaction chromatography Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- JURZHOVRCOWZFN-UHFFFAOYSA-N notoginsenoside R1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(CC34C)OC6OC(COC7OCC(O)C(O)C7O)C(O)C(O)C6O)C JURZHOVRCOWZFN-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- CKUVNOCSBYYHIS-UHFFFAOYSA-N (20R)-ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1O CKUVNOCSBYYHIS-UHFFFAOYSA-N 0.000 description 1
- CKUVNOCSBYYHIS-IRFFNABBSA-N (20S)-ginsenoside Rh2 Chemical compound O([C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CKUVNOCSBYYHIS-IRFFNABBSA-N 0.000 description 1
- CKUVNOCSBYYHIS-LGYUXIIVSA-N 20(R)-Ginsenoside Rh2 Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@H]1C(C)(C)[C@H]2[C@@](C)([C@H]3[C@](C)([C@@]4(C)[C@H]([C@H](O)C3)[C@@H]([C@](O)(CC/C=C(\C)/C)C)CC4)CC2)CC1 CKUVNOCSBYYHIS-LGYUXIIVSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BGHNZAWRRWLKPO-UHFFFAOYSA-N Ginsenoside F1 Natural products CC(=C)CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C BGHNZAWRRWLKPO-UHFFFAOYSA-N 0.000 description 1
- SWIROVJVGRGSPO-UHFFFAOYSA-N Ginsenoside F2 Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O SWIROVJVGRGSPO-UHFFFAOYSA-N 0.000 description 1
- AVTXSAWPGCSYFO-UHFFFAOYSA-N Ginsenoside Ia Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O AVTXSAWPGCSYFO-UHFFFAOYSA-N 0.000 description 1
- LLPWNQMSUYAGQI-QBQUQATFSA-N Ginsenoside R1 Natural products O([C@](CC/C=C(\C)/C)(C)[C@@H]1[C@H]2[C@@H](O)C[C@H]3[C@](C)([C@]2(C)CC1)C[C@H](O[C@@H]1[C@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)CO2)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1C(C)(C)[C@@H](O)CC[C@]31C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 LLPWNQMSUYAGQI-QBQUQATFSA-N 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- -1 bout Species 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- FVIZARNDLVOMSU-IRFFNABBSA-N ginsenoside C-K Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O FVIZARNDLVOMSU-IRFFNABBSA-N 0.000 description 1
- YNBYFOIDLBTOMW-QHNUHGIDSA-N ginsenoside C-Y Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O YNBYFOIDLBTOMW-QHNUHGIDSA-N 0.000 description 1
- XNGXWSFSJIQMNC-FIYORUNESA-N ginsenoside F1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@H](O)[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XNGXWSFSJIQMNC-FIYORUNESA-N 0.000 description 1
- SWIROVJVGRGSPO-JBVRGBGGSA-N ginsenoside F2 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SWIROVJVGRGSPO-JBVRGBGGSA-N 0.000 description 1
- CJFGBCWGOQRURQ-JFJIKBJRSA-N ginsenoside Mc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O CJFGBCWGOQRURQ-JFJIKBJRSA-N 0.000 description 1
- CJFGBCWGOQRURQ-UHFFFAOYSA-N ginsenoside Mc Natural products C1CC(C2(CCC3C(C)(C)C(O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CJFGBCWGOQRURQ-UHFFFAOYSA-N 0.000 description 1
- 210000004349 growth plate Anatomy 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- LLPWNQMSUYAGQI-UHFFFAOYSA-N notoginsenoside r1 Chemical compound C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)CO3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O LLPWNQMSUYAGQI-UHFFFAOYSA-N 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/06—Amino acid
- A23V2250/0612—Carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
Abstract
Description
본 발명은 발효 산양삼추출액의 제조방법 및 이에 의하여 제조된 발효 산양삼추출액에 관한 것으로, 더욱 구체적으로 액체 발효 또는 고체 발효를 이용한 발효 산양삼추출액의 제조방법 및 이에 의하여 제조된 발효 산양삼추출액에 관한 것이다.The present invention relates to a method for preparing a fermented goat ginseng extract and a fermented goat ginseng extract prepared thereby, and more particularly to a fermented ginseng extract using liquid fermentation or solid fermentation and a fermented ginseng extract prepared thereby.
산야초의 대부분은 원물 형태로 이용 또는 유통 되고 있다. 이는 낮은 가공 기술로 인한 낮은 활용도, 그리고 부족한 기능성 효능 규명으로 소비자들에게 산야초의 우수성이 상대적으로 알려지지 않기 때문이다. 산야초를 가공한 제품은 대부분이 발효 효소형태의 액상차 또는 발효음료 형태가 주를 이루고 있으며 대부분은 온라인마켓을 통하여 판매되고 있다. Most of the sanayas are used or distributed in the form of raw materials. This is because the low productivity due to the low processing technology and the lack of the superiority of the mountain pasture to the consumers due to the lack of functional effect identification are relatively unknown. Most of the processed products of Sanayasu mainly consist of liquid or fermented beverages in the form of fermentation enzymes, most of which are sold through the online market.
고령화 시대에 접어들고 평균 수명이 높아지면서 건강 유지에 대한 관심은 꾸준하게 높아지고 있다. 이에 다양한 기능성을 가진 소재와 식품에 대한 관심이 높아지고 있으며, 이를 과학적으로 검증하고, 과학적 기술과 성분이 가미된 제품에 대한 수요가 높아지고 있다. As the age of the elderly increases and life expectancy increases, interest in maintaining health is steadily increasing. Accordingly, interest in materials and foods having various functionalities is increasing, and there is a growing demand for products that have been scientifically verified and added with scientific technology and ingredients.
최근 트렌드로 자리잡은 건강한 식품을 찾는 소비자의 인식과 더불어 전통식품의 효능이 재조명되고 있어 산야초 시장은 현재 약 200억원대의 규모를 갖추고 있다. In addition to the recognition of consumers who are looking for healthy food, which has become a trend in recent years, the efficacy of traditional foods is being reexamined.
산양삼은 피부보습, 골질환, 탈모, 불임 예방 등의 분야에서 약학 조성물로 연구가 진행되고 있으며 폐경기 유도에 의하여 유발되는 골밀도 저하, 성장판 비후 등의 증세를 개선하기 위하여 추출물과 분획물을 사용하고 있다. 피부 개선 기능 관련하여는 진세노사이드 Rb1과 Rh1+Rc가 많이 함유되어 있고, 보습 효능을 보인다.Goat ginseng is being studied as a pharmaceutical composition in areas such as skin moisturizing, bone disease, hair loss, and infertility prevention, and extracts and fractions are used to improve symptoms such as lowering of bone density and growth plate thickening caused by menopause induction. Regarding the skin improvement function, it contains a lot of ginsenosides Rb1 and Rh1 + Rc, and shows moisturizing effect.
본 발명은 산양삼을 액체발효, 고체 발효를 통해 원래 가지고 있는 고유의 진세노사이드와 더불어 지방산 분해에 꼭 필요한 성분인 L-카르니틴을 함유하는 발효 산양삼 추출물을 제조하는 기술과 그 소재에 관한 것이다.The present invention relates to a technique for producing a fermented goat's ginseng extract containing L-carnitine, which is an essential ingredient for decomposing fatty acids, as well as inherent ginsenosides originally possessed through liquid fermentation and solid fermentation of goat ginseng.
본 발명은 산양삼의 성분인 진세노사이드의 함량을 증가시키고, 산양삼에는 존재하지 않던 L-카르니틴을 함유하는 발효 산양삼추출액을 제조하기 위한 제조방법을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a process for producing an extract of fermented goat's ginseng containing L-carnitine, which increases the content of ginsenoside, which is a component of goat's ginseng, and does not exist in goat's ginseng.
본 발명은 또한, 상기 제조방법을 이용하여 제조된 발효 산양삼추출액을 제공하는 것을 목적으로 한다.Another object of the present invention is to provide a fermented goat ginseng extract prepared by using the above production method.
본 발명의 한 양태에 따르면, 본 발명은According to one aspect of the present invention,
A) 산양삼을 동결 건조 및 분말화 하는 단계;A) freeze-drying and pulverizing the goat's ginseng;
B) 상기 A) 단계에서 분말화한 산양삼 분말을 증류수와 혼합하여 멸균시키는 단계; B) sterilizing the raw goat's milk powder powdered in step A) with distilled water;
C) 상기 B) 단계의 멸균액을 곰팡이 균으로 접종하는 단계; 및C) Inoculating the sterilized liquid of step B) with molds; And
D) 상기 C) 단계의 균이 접종된 멸균액을 발효시키는 단계;를 포함하는 액체 발효법을 이용한 발효 산양삼추출액의 제조방법을 제공한다. D) fermenting the sterilized liquid inoculated with the microorganism of step C). The present invention also provides a method for producing fermented goat ginseng extract using the liquid fermentation method.
본 발명은 또한, The present invention also relates to
A') 산양삼을 동결 건조 및 분말화 하는 단계;A ') lyophilization and pulverization of goat ginseng;
B') 상기 A') 단계에서 분말화한 산양삼 분말을 증류수와 혼합하여 반죽을 만들어 밀누룩과 혼합한 후, 멸균하는 단계; B ') mixing raw ginseng powder powdered in step A') with distilled water to prepare a dough, mixing it with wheat germ, and sterilizing it;
C') 상기 B') 단계의 반죽을 곰팡이 균으로 접종하는 단계; 및C ') Inoculating the dough of step B' into molds; And
D') 상기 C') 단계의 균이 접종된 반죽을 발효시키는 단계;를 포함하는 고체 발효법을 이용한 발효 산양삼추출액의 제조방법을 제공한다. D ') fermenting the dough inoculated with the microorganism of step C'). The present invention also provides a method for producing fermented goat ginseng extract using the solid fermentation method.
종래에 산양삼과 같은 산야초는 낮은 가공 기술로 인해 그 효과의 우수성이 상대적으로 알려져 있지 않았다. 이에 본 발명자들은 산야초 중 산양삼의 추출 방법을 연구한 결과, 산양삼을 액체 발효 또는 고체 발효하여 추출할 경우, 진세노사이드의 함량이 증가되고, 산양삼에는 없던 성분인 L-카르니틴을 함유할 수 있음을 확인하고, 본 발명을 완성하게 되었다.Conventionally, Yamatake, such as goat's ginseng, is relatively inferior in its effect due to low processing technology. The inventors of the present invention have found that when extracting the goat's ginseng by liquid fermentation or solid fermentation, the ginsenoside content is increased and L-carnitine, which is a component not found in the goat's ginseng, can be contained And the present invention was completed.
본 발명의 액체 발효법 또는 고체 발효법을 이용한 발효 산양삼추출액의 제조방법에 있어서, 상기 C) 또는 C') 단계의 곰팡이 균은 산양삼을 발효하기 위한 어떠한 곰팡이 균도 이용될 수 있으며, 바람직하게는 라이조프스 올리고스포루스 (Rhyzopus oligosporus) 또는 리조퍼스 오리재 (Rhizopus oryzae)인 것을 특징으로 한다.In the method for producing the fermented goat's ginseng extract using the liquid fermentation method or the solid fermentation method of the present invention, the fungus of step C) or step C ') may be any fungus for fermenting the goat ginseng, Rhizopus oligosporus or Rhizopus oryzae . ≪ IMAGE >
본 발명의 액체 발효법 또는 고체 발효법을 이용한 발효 산양삼추출액의 제조방법에 있어서, 상기 D) 또는 D') 단계의 발효는 20 내지 40℃에서 5 내지 15일간 발효하는 것을 특징으로 한다.In the method for producing fermented goat's ginseng extract using the liquid fermentation method or the solid fermentation method of the present invention, the fermentation in step D) or step D ') is performed at 20 to 40 ° C for 5 to 15 days.
본 발명의 일 실험예에 따르면, 상기 발효 온도에서 발효 기간을 증가시킬수록 진세노이드 함량 및 L-카르니틴 함량이 증가되는 것을 확인하였다.According to one experimental example of the present invention, it was confirmed that as the fermentation period was increased at the fermentation temperature, the ginsenoside content and L-carnitine content were increased.
본 발명의 다른 양태에 따르면, 본 발명은 상기 액체 발효법 또는 고체 발효법을 이용한 제조방법에 따라 제조된 발효 산양삼추출액을 제공한다. According to another aspect of the present invention, there is provided a fermented goat's ginseng extract prepared by the liquid fermentation method or the solid fermentation method.
본 발명의 발효 산양삼추출액에 있어서, 상기 발효 산양삼추출액은 진세노사이드의 함량이 증가된 것을 특징으로 한다.In the fermented goat ginseng extract of the present invention, the fermented goat ginseng extract is characterized in that the ginsenoside content is increased.
또한, 본 발명의 발효 산양삼추출액은 L-카르니틴을 함유하는 것을 특징으로 한다.Further, the fermented goat's ginseng extract of the present invention is characterized by containing L-carnitine.
본 발명의 일 실험예에 따르면, 본 발명의 액체 발효법 또는 고체 발효법에 따라 제조된 발효 산양삼추출액은 발효하지 않은 산양삼추출액 보다 진세노사이드 함량이 증가되었으며, 발효하지 않은 산양삼추출액에서는 검출되지 않은 L-카르니틴이 산양삼을 발효할 경우, 검출되는 것을 확인하였다. 이러한 결과는, 본 발명의 발효 산양삼 제조 방법은 기능성 성분을 증가 및 생성된 발효 산양삼추출액을 제조할 수 있음을 보여준다.According to one experimental example of the present invention, the fermented goat's ginseng extract prepared according to the liquid fermentation method or the solid fermentation method of the present invention had an increased ginsenoside content than the fermented goat's ginseng extract, and the undetected L- It was confirmed that carnitine was detected when fermenting goat ginseng. These results show that the fermented goat ginseng method of the present invention can increase the functional ingredient and produce the fermented goat ginseng extract.
전술한 바와 같이, 본 발명에 따른 발효 산양삼추출액의 제조방법은 산양삼의 우수한 가공 기술로 산양삼의 기능성분을 증가시킬 수 있으며, 상기 제조방법에 따라 제조된 발효 산양삼추출액의 경우, 기능 성분인 진세노사이드의 함량이 증가되고 기존에는 없던 L-카르니틴 성분이 생성 및 증가되어 다양한 기능성 식품으로 이용될 수 있다.As described above, the method of manufacturing fermented goat ginseng extract according to the present invention can increase functional ingredients of goat's ginseng with superior processing technology of goat's ginseng. In the case of fermented goat ginseng extract prepared according to the above-described method, The side content is increased and the L-carnitine ingredient, which has not existed before, is produced and increased, so that it can be used as various functional foods.
도 1은 실험예 2-1의 Peak chromatogram 결과를 나타낸다.1 shows the results of the peak chromatogram of Experimental Example 2-1.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.
<실시예><Examples>
실시예 1: 액체발효법를 이용한 발효 산양삼추출액의 제조Example 1: Preparation of fermented goat ginseng extract using liquid fermentation
산양삼을 흐르는 물에 가볍게 수세한 다음 초저온냉동고에서 12시간 동안 동결 후, 동결 건조기를 이용하여 3일간 건조하였다. 건조한 산양삼은 믹서기를 이용하여 분말화 하였으며, 분말화한 산양삼 분말을 삼각플라스크에 증류수와 함께 1 : 100(w/v)의 비율로 혼합 후 121℃에서 15분간 멸균하였다. The water was washed lightly with flowing goat ginseng, frozen in a cryogenic freezer for 12 hours, and then dried in a freeze dryer for 3 days. The dry goat's ginseng was powdered using a blender, and the powdered goat's ginseng powder was mixed with distilled water in an Erlenmeyer flask at a ratio of 1: 100 (w / v) and sterilized at 121 ° C for 15 minutes.
이후 Rhyzopus oligosporus 균의 포자(3.0x106/ml)를 상기 산양삼 멸균액 대비 1% (v/v)의 양을 접종 하였다. 접종한 산양삼 발효액은 면전으로 입구를 막아준 후, 30℃ 인큐베이터에서 각각 7, 11일간 발효하여 발효 산양삼추출액을 제조하였다. Then , spores (3.0 x 10 6 / ml) of Rhyzopus oligosporus were inoculated in an amount of 1% (v / v) relative to the sterilized goat's ginseng. The inoculated goat 's fermentation broth was blocked by an inlet and fermented for 7 or 11 days in a 30 ℃ incubator to produce fermented goat ginseng extract.
실시예 2: 고체발효법을 이용한 발효 산양삼의 제조Example 2: Preparation of fermented soybean ginseng by solid fermentation
산양삼을 흐르는 물에 가볍게 수세한 다음 초저온냉동고에서 12 시간 동안 동결 후, 동결 건조기를 이용하여 3일간 건조하였다. 건조 한 산양삼은 믹서기를 이용하여 분말화 하였다. 분말화한 산양삼 가루와 물을 1:1(w/w)로 섞어 반죽을 만들고 밀누룩과 같이 둥근원통모양에 가운데부분이 눌려있는 모양으로 성형 하였다. The water was washed lightly with flowing goat ginseng, frozen in a cryogenic freezer for 12 hours, and then dried in a freeze dryer for 3 days. The dried goat ginseng was powdered using a blender. Powdered ginseng powder and water were mixed in a ratio of 1: 1 (w / w) to form a dough.
상기 성형한 산양삼 반죽을 철제 용기로 옮겨 담은 후, 121℃에서 15분간 멸균하고 상온에서 식혀 주었다. 멸균한 산양삼은 클린벤치 내에서 3.0x106/ml로 준비한 Rhyzopus oligosporus 균의 포자를 산양삼 건조 중량 대비 1% (v/w)의 양으로 접종하였다. 접종된 산양삼은 랩으로 용기 표면을 한 번 덮어 준 후, 30℃ 인큐베이터에서 각각 4, 7일간 발효하였다. 균사가 적절히 자라 발효가 끝난 산양삼은 동결 건조 후 가루 상태로 준비하였다.The molded goat's gum dough was transferred into iron containers, sterilized at 121 ° C for 15 minutes, and cooled at room temperature. The sterilized goat ginseng was inoculated with Rhyzopus oligosporus spores of 3.0 × 10 6 / ml in a clean bench in an amount of 1% (v / w) based on the dry weight of the ginseng root. The inoculated goat ginseng was covered with a lap once and then fermented for 4 or 7 days in a 30 ° C incubator. After the fermentation, the goat ginseng was freeze dried and prepared as powder.
<실험예><Experimental Example>
실험예 1: 진세노사이드의 정량 분석Experimental Example 1: Quantitative analysis of ginsenoside
1) 액체 발효한 발효 산양삼추출액의 진세노사이드 분석1) Ginsenoside analysis of liquid fermented goat ginseng extract
상기 실시예 1에서 제조한 액체 발효한 발효 산양삼추출액의 진세노사이드를 분석하였다. 대조군으로는 발효를 진행하지 않은 산양삼 멸균액을 이용하였다.The ginsenosides of the liquid fermented fermented goat ginseng extract prepared in Example 1 were analyzed. As a control group, a goat germ sterilization solution which did not undergo fermentation was used.
구체적으로, 발효 산양삼추출액을 50ml conical tube에 옮겨 담은 후 7220xg 에서 10분간 원심 분리한 다음, 그 상등액을 0.2μm membrane syringe filter (ANOW, China)를 이용하여 필터하였다. 그 다음, 필터한 용액 1ul를 UPLC 시스템에 주입하여 분석하였다. 분석 조건은 아래 표 1과 같으며, 분석한 결과를 표 2에 나타내었다.Specifically, the fermented goat's ginseng extract was transferred into a 50 ml conical tube and centrifuged at 7220 × g for 10 minutes. The supernatant was filtered using a 0.2 μm membrane syringe filter (ANOW, China). Then, 1 ul of the filtered solution was injected into the UPLC system and analyzed. The analysis conditions are shown in Table 1 below, and the results are shown in Table 2.
B: Acetonitrile (0.1% formic acid) A: triply distilled water (0.1% formic acid)
B: Acetonitrile (0.1% formic acid)
GradientGradient
MS conditionMS condition
Ginsenoside Rb2: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rb3: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rc: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 35 V
Ginsenoside Rd: ESI+, 969.7 m/z, CE: 1.5 kV, CV: 20 V
Ginsenoside Re: ESI-, 945.6 m/z, CE: 0.8 kV, CV: 45 V
Ginsenoside Rf: ESI+, 823.6 m/z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rg1: ESI+, 823.6 m/z, CE: 1.5 kV, CV: 25 V
Ginsenoside Rg2: ESI-, 783.6 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside Rg3: ESI-, 807.6 m/z, CE: 0.8 kV, CV: 50 V
Ginsenoside Rh1: ESI-, 638.5 m/z, CE: 0.8 kV, CV: 20 V
Ginsenoside Ro: ESI-, 955.5 m/z, CE: 0.8 kV, CV: 30 V
Ginsenoside R1: ESI-, 931.7 m/z, CE: 0.8 kV, CV: 45 VGinsenoside Rb1: ESI +, 1132 m / z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rb2: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rb3: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rc: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 35 V
Ginsenoside Rd: ESI +, 969.7 m / z, CE: 1.5 kV, CV: 20 V
Ginsenoside Re: ESI-, 945.6 m / z, CE: 0.8 kV, CV: 45 V
Ginsenoside Rf: ESI +, 823.6 m / z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rg1: ESI +, 823.6 m / z, CE: 1.5 kV, CV: 25 V
Ginsenoside Rg2: ESI-, 783.6 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside Rg3: ESI-, 807.6 m / z, CE: 0.8 kV, CV: 50 V
Ginsenoside Rh1: ESI-, 638.5 m / z, CE: 0.8 kV, CV: 20 V
Ginsenoside Ro: ESI-, 955.5 m / z, CE: 0.8 kV, CV: 30 V
Ginsenoside R1: ESI-, 931.7 m / z, CE: 0.8 kV, CV: 45 V
(g/kg)Total ginsenoside
(g / kg)
(g/kg)Ginsenoside Rd
(g / kg)
(g/kg)Ginsenoside Rg3
(g / kg)
그 결과, 상기 표 2에서 확인할 수 있는 바와 같이, 총 진세노사이드의 경우 발효를 하지 않은 산양삼 멸균액에서는 20.78 g/kg의 양이 확인되었고, 3일차 발효 산양삼추출액의 경우 21.08 g/kg로 산양삼 멸균액과 비슷하였으나, 7일차 발효 산양삼추출액의 경우 일반 산양삼 멸균액 대비 20% 증가한 24.96 g/kg의 양이 확인되었다. 즉, 발효 과정을 거치면서 총 진세노사이드의 양이 증가하는 것을 알 수 있다. As a result, as shown in Table 2, the total ginsenoside amount was found to be 20.78 g / kg in the sterilized goat's germ without fermentation, and 21.08 g / kg in the 3-day fermented goat ginseng extract. The amount of 24.96 g / kg of soybean fermented soybean ginseng extract increased by 20% compared with that of general ginseng fermented milk. That is, it can be seen that the amount of total ginsenosides increases during the fermentation process.
또한, 진세노사이드 Rd의 양은 발효하지 않은 산양삼 멸균액에서 1.67 g/kg, 3일차 발효 산양삼추출액에서는 2.11 g/kg 그리고 7일차 발효 산양삼추출액에서는 산양삼 멸균액 대비 3.6배 증가한 6.06 g/kg의 양이 확인되었다. 즉, 발효 과정을 거치면서 진세노사이드 Rd의 양이 증가하는 것을 알 수 있다.The amount of ginsenoside Rd was 1.67 g / kg in the fermented goat's germ extract, 2.11 g / kg in the 3-day fermented goat ginseng extract, and 6.06 g / kg in the 7-day fermented goat ginseng extract, . That is, it can be seen that the amount of ginsenoside Rd increases during the fermentation process.
또한, 진세노사이드 Rg3는 발효하지 않은 산양삼 멸균액에서 0.69 g/kg, 7일차 발효 산양삼추출액에서는 산양삼 멸균액 대비 1.4배 증가 한 0.95 g/kg의 양이 확인되었다. 즉, 발효 과정을 거치면서 진세노사이드 Rg3의 양이 증가하는 것을 알 수 있다. In addition, 0.92 g / kg of ginsenoside Rg3 was found to be 0.69 g / kg in the non-fermented goat germ and 0.95 g / kg in the 7th fermented goat germ extract. That is, it can be seen that the amount of ginsenoside Rg3 increases during the fermentation process.
2) 고체 발효한 발효 산양삼의 진세노사이드 분석2) Analysis of ginsenosides in fermented soybean ginseng by solid fermentation
상기 실시예 2에서 제조한 고체 발효한 발효 산양삼의 진세노사이드를 분석하였다. 대조군으로는 발효를 진행하지 않은 산양삼을 이용하였다.The ginsenosides of the fermented fermented goat ginseng prepared in Example 2 were analyzed. As a control group, goat ginseng without fermentation was used.
구체적으로, 발효하지 않은 산양삼, 3일 발효한 산양삼, 7일 발효한 산양삼을10 mg/ml 의 농도로 70% 에탄올을 이용하여 1시간동안 ultrasonication assisted extraction 방법(30°C, 30분)을 이용하여 추출하였다.Specifically, unfermented goat ginseng, 3 days fermented goat ginseng, and 7 days fermented goat ginseng were subjected to ultrasonication assisted extraction (30 ° C, 30 minutes) using 70% ethanol at a concentration of 10 mg / ml for 1 hour Respectively.
상기 추출한 추출액은 7220 xg에서 10분간 원심 분리하고, 그 상등액은 0.2 μm membrane syringe filter (ANOW, China)를 이용하여 필터하였다. 필터한 용액 1ul를 UPLC 시스템에 주입하여 분석하였다. 분석 조건은 하기 표 3에 기재하였으며, 분석 결과는 표 4에 나타내었다.The extracted extract was centrifuged at 7220 xg for 10 minutes, and the supernatant was filtered using a 0.2 μm membrane syringe filter (ANOW, China). 1ul of the filtered solution was injected into the UPLC system and analyzed. The analytical conditions are shown in Table 3 below, and the analytical results are shown in Table 4.
B: Acetonitrile (0.1% formic acid) A: triply distilled water (0.1% formic acid)
B: Acetonitrile (0.1% formic acid)
radientradient
MS conditionMS condition
Ginsenoside Rb2: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rb3: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rc: ESI+, 1101.6 m/z, CE: 1.5 kV, CV: 35 V
Ginsenoside Rd: ESI+, 969.7 m/z, CE: 1.5 kV, CV: 20 V
Ginsenoside Re: ESI-, 945.6 m/z, CE: 0.8 kV, CV: 45 V
Ginsenoside Rf: ESI+, 823.6 m/z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rg1: ESI+, 823.6 m/z, CE: 1.5 kV, CV: 25 V
Ginsenoside Rg2: ESI-, 783.6 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside Rg3: ESI-, 807.6 m/z, CE: 0.8 kV, CV: 50 V
Ginsenoside Rh1: ESI-, 638.5 m/z, CE: 0.8 kV, CV: 20 V
Ginsenoside Rh2: ESI-, 667.5 m/z, CE: 0.8 kV, CV: 15 V
Ginsenoside Ro: ESI-, 955.5 m/z, CE: 0.8 kV, CV: 30 V
Ginsenoside Compound K: ESI+, 645.5 m/z, CE: 0.8 kV, CV: 45 V
Ginsenoside Compound Y: ESI+, 777.6 m/z, CE: 0.8 kV, CV: 15 V
Ginsenoside Compound O: ESI+, 939.7 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside Mc: ESI+, 754.99 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside Mc1: ESI+, 939.7 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside F1: ESI+, 661.6 m/z, CE: 0.8 kV, CV: 25 V
Ginsenoside F2: ESI+, 829.7 m/z, CE: 0.8 kV, CV: 10 VGinsenoside Rb1: ESI +, 1132 m / z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rb2: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rb3: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 15 V
Ginsenoside Rc: ESI +, 1101.6 m / z, CE: 1.5 kV, CV: 35 V
Ginsenoside Rd: ESI +, 969.7 m / z, CE: 1.5 kV, CV: 20 V
Ginsenoside Re: ESI-, 945.6 m / z, CE: 0.8 kV, CV: 45 V
Ginsenoside Rf: ESI +, 823.6 m / z, CE: 1.5 kV, CV: 10 V
Ginsenoside Rg1: ESI +, 823.6 m / z, CE: 1.5 kV, CV: 25 V
Ginsenoside Rg2: ESI-, 783.6 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside Rg3: ESI-, 807.6 m / z, CE: 0.8 kV, CV: 50 V
Ginsenoside Rh1: ESI-, 638.5 m / z, CE: 0.8 kV, CV: 20 V
Ginsenoside Rh2: ESI-, 667.5 m / z, CE: 0.8 kV, CV: 15 V
Ginsenoside Ro: ESI-, 955.5 m / z, CE: 0.8 kV, CV: 30 V
Ginsenoside Compound K: ESI +, 645.5 m / z, CE: 0.8 kV, CV: 45 V
Ginsenoside Compound Y: ESI +, 777.6 m / z, CE: 0.8 kV, CV: 15 V
Ginsenoside Compound O: ESI +, 939.7 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside Mc: ESI +, 754.99 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside Mc1: ESI +, 939.7 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside F1: ESI +, 661.6 m / z, CE: 0.8 kV, CV: 25 V
Ginsenoside F2: ESI +, 829.7 m / z, CE: 0.8 kV, CV: 10 V
그 결과 상기 표 4에서 확인할 수 있듯이, 총 진세노사이드의 경우 발효하지 않은 산양삼에서는 20.72 g/kg의 양이 확인되었고, 4일차 발효 산양삼의 경우 발효하지 않은 산양삼 대비 약 32%증가한 27.39 g/k의 양이 확인 되었다. 또한, 7일차 발효산양삼의 경우 발효하지 않은 산양삼 대비 약 67%, 4일차 발효 산양삼 대비 약 26% 증가한 34.64 g/kg의 양이 확인 되었다. 즉, 발효 과정을 거치면서 총 진세노사이드의 양이 증가하는 것을 알 수 있다.As a result, as shown in Table 4, the total ginsenoside amount was 20.72 g / kg in the non-fermented goat ginseng, and in the case of the 4-day fermented goat ginseng, 27.39 g / k Was confirmed. In addition, the amount of 34.64 g / kg of 7 days fermented goat ginseng was increased by 67% compared to non fermented goat ginseng and about 26% higher than that of 4 days fermented goat ginseng. That is, it can be seen that the amount of total ginsenosides increases during the fermentation process.
실험예 2: L-카르니틴의 정량 분석Experimental Example 2: Quantitative analysis of L-carnitine
1) 액체 발효한 발효 산양삼추출액의 L-카르니틴 분석1) L-carnitine analysis of liquid fermented soybean ginseng extract
상기 실시예 1에서 제조한 액체 발효한 발효 산양삼추출액의 L-카르니틴을를 분석하였다. 대조군으로는 발효를 진행하지 않은 산양삼 멸균액을 이용하였다.L-carnitine of the liquid fermented fermented goat ginseng extract prepared in Example 1 was analyzed. As a control group, a goat germ sterilization solution which did not undergo fermentation was used.
발효 산양삼추출액을 50ml conical tube에 옮겨 담은 후 7220 xg에서 10분간 원심 분리하고, 그 상등액을 0.2 μm membrane syringe filter (ANOW, China)를 이용하여 필터하였다. 필터한 용액 1ul를 UPLC 시스템에 주입하여 분석하였다. 분석 조건은 아래 표 5와 같으며, 그 결과를 도 1에 나타내었다.The fermented goat extract was transferred into a 50 ml conical tube and centrifuged at 7220 xg for 10 min. The supernatant was filtered through a 0.2 μm membrane syringe filter (ANOW, China). 1ul of the filtered solution was injected into the UPLC system and analyzed. The analysis conditions are shown in Table 5 below, and the results are shown in FIG.
B: Acetonitrile (0.1% formic acid) A: triply distilled water (15 mM Ammonium formate and 0.1% formic acid)
B: Acetonitrile (0.1% formic acid)
그 결과, 도 1에서 확인할 수 있듯이, 발효하지 않은 산양삼 멸균액에서는 검출되지 않은 L-카르니틴이 발효 산양삼추출액에서 L-카르니틴이 생산되었으며, 발효 진행 시간이 증가함에 따라 L-카르니틴의 생성량이 증가하는 것을 확인하였다.As a result, as can be seen from FIG. 1, L-carnitine was detected in the fermented goat's ginseng extract, which was not detected in the fermented goat's germ extract, and the amount of L-carnitine was increased Respectively.
2) 고체 발효한 발효 산양삼의 L-카르니틴 분석2) L-carnitine analysis of fermented goat's milk with solid fermentation
상기 실시예 2에서 제조한 고체 발효한 발효 산양삼의 L-카르니틴을 분석하였다. 대조군으로는 발효를 진행하지 않은 산양삼을 이용하였다.The L-carnitine of the fermented fermented goat ginseng prepared in Example 2 was analyzed. As a control group, goat ginseng without fermentation was used.
구체적으로, 발효하지 않은 산양삼, 4일 발효한 산양삼, 7일 발효한 산양삼을 10 mg/ml 의 농도로 70% 에탄올을 이용하여 1시간동안 ultrasonication assisted extraction 방법(30°C, 30분)을 이용하여 추출하였다.Specifically, unfermented goat ginseng, 4 days fermented goat ginseng, and 7 days fermented goat ginseng were subjected to ultrasonication assisted extraction (30 ° C, 30 minutes) using 70% ethanol at a concentration of 10 mg / ml for 1 hour Respectively.
상기 추출한 추출액은 7220xg에서 10분간 원심 분리하고, 그 상등액은 0.2 μm membrane syringe filter (ANOW, China)를 이용하여 필터하였다. 필터한 용액 1ul을 UPLC 시스템에 주입하여 분석하였다. 분석 조건은 아래 표 6과 같으며, 그 결과는 표 7에 나타내었다.The extracted extract was centrifuged at 7220 xg for 10 minutes, and the supernatant was filtered using a 0.2 μm membrane syringe filter (ANOW, China). 1ul of the filtered solution was injected into the UPLC system and analyzed. The analysis conditions are shown in Table 6 below, and the results are shown in Table 7.
B: Acetonitrile (0.1% formic acid) A: triply distilled water (15 mM Ammonium formate and 0.1% formic acid)
B: Acetonitrile (0.1% formic acid)
그 결과, 상기 표 7에서 확인할 수 있듯이, L-카르니틴성분이 발효하지 않은 산양삼에서는 검출되지 않았으나 4일차 발효산양삼에서는 60 mg/kg의 양이 확인되었고, 7일차 발효산양삼의 경우 4일차 발효산양삼 대비 약 66% 증가한 100 mg/kg의 양이 확인되었다. 즉, 발효를 진행할수록 L-카르니틴성분이 생성 및 증가하는 것을 알 수 있다.As a result, as shown in Table 7, the amount of L-carnitine was not detected in the non-fermented goat's ginseng, but the amount of 60 mg / kg was observed in the fermented goat ginseng at 4 days. In the case of 7 days fermented goat ginseng, An amount of 100 mg / kg, which was increased by about 66%, was confirmed. That is, as the fermentation proceeds, the L-carnitine component is produced and increased.
Claims (7)
B) 상기 A) 단계에서 분말화한 산양삼 분말을 증류수와 혼합하여 멸균시키는 단계;
C) 상기 B) 단계의 멸균액을 곰팡이 균으로 접종하는 단계; 및
D) 상기 C) 단계의 균이 접종된 멸균액을 발효시키는 단계;를 포함하는 액체 발효법을 이용한 발효 산양삼추출액의 제조방법.
A) freeze-drying and pulverizing the goat's ginseng;
B) sterilizing the raw goat's milk powder powdered in step A) with distilled water;
C) Inoculating the sterilized liquid of step B) with molds; And
D) fermenting the sterilized liquid inoculated with the bacteria of step C).
B') 상기 A') 단계에서 분말화한 산양삼 분말을 증류수와 혼합하여 반죽을 만들어 밀누룩과 혼합한 후, 멸균하는 단계;
C') 상기 B') 단계의 반죽을 곰팡이 균으로 접종하는 단계; 및
D') 상기 C') 단계의 균이 접종된 반죽을 발효시키는 단계;를 포함하는 고체 발효법을 이용한 발효 산양삼추출액의 제조방법.
A ') lyophilization and pulverization of goat ginseng;
B ') mixing raw ginseng powder powdered in step A') with distilled water to prepare a dough, mixing it with wheat germ, and sterilizing it;
C ') Inoculating the dough of step B' into molds; And
D ') fermenting the dough inoculated with the microorganism of step C') by using the solid fermentation method.
상기 C) 또는 C') 단계의 곰팡이 균은 라이조프스 올리고스포루스 (Rhyzopus oligosporus) 또는 리조퍼스 오리재 (Rhizopus oryzae)인 것인
발효 산양삼추출액의 제조방법.
3. The method according to claim 1 or 2,
Wherein the fungus of step C) or step C ') is Rhizopus oligosporus or Rhizopus oryzae.
A method for producing fermented goat ginseng extract.
상기 D) 또는 D') 단계의 발효는 20 내지 40℃에서 5 내지 15일간 발효하는 것인
발효 산양삼추출액의 제조방법.
3. The method according to claim 1 or 2,
Wherein the fermentation in step D) or step D 'is carried out at 20 to 40 DEG C for 5 to 15 days
A method for producing fermented goat ginseng extract.
A fermented goat ginseng extract prepared according to the production method of any one of claims 1 and 2.
상기 발효 산양삼 추출액은 진세노사이드의 함량이 증가된 것인
발효 산양삼 추출액.
6. The method of claim 5,
The fermented goat's ginseng extract showed that the content of ginsenosides was increased
Fermented goat ginseng extract.
상기 발효 산양삼 추출액은 L-카르니틴을 함유하는 것인
발효 산양삼 추출액.6. The method of claim 5,
The fermented goat's ginseng extract contains L-carnitine
Fermented goat ginseng extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170181261A KR102495635B1 (en) | 2017-12-27 | 2017-12-27 | Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170181261A KR102495635B1 (en) | 2017-12-27 | 2017-12-27 | Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20190079213A true KR20190079213A (en) | 2019-07-05 |
KR102495635B1 KR102495635B1 (en) | 2023-02-03 |
Family
ID=67225662
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170181261A KR102495635B1 (en) | 2017-12-27 | 2017-12-27 | Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102495635B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220103413A (en) * | 2021-01-15 | 2022-07-22 | 조성근 | Preparation method of fermented wild-simulated ginseng |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080103299A (en) * | 2007-05-23 | 2008-11-27 | 주식회사 두산 | Fermented ginseng containing bio-conversed ginsenoside metabolites increased by co-fermentation of fungi and lactic acid bacteria |
KR100997054B1 (en) * | 2010-06-11 | 2010-11-30 | 홍진석 | Fermentated woods grown ginseng roots and fermentation method for the same |
-
2017
- 2017-12-27 KR KR1020170181261A patent/KR102495635B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080103299A (en) * | 2007-05-23 | 2008-11-27 | 주식회사 두산 | Fermented ginseng containing bio-conversed ginsenoside metabolites increased by co-fermentation of fungi and lactic acid bacteria |
KR100997054B1 (en) * | 2010-06-11 | 2010-11-30 | 홍진석 | Fermentated woods grown ginseng roots and fermentation method for the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20220103413A (en) * | 2021-01-15 | 2022-07-22 | 조성근 | Preparation method of fermented wild-simulated ginseng |
Also Published As
Publication number | Publication date |
---|---|
KR102495635B1 (en) | 2023-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107929339B (en) | Preparation method of black ginseng | |
KR101423100B1 (en) | Fabrication method of enhancing ginsenoside Rg3 and Rb1 of red ginseng | |
KR101164529B1 (en) | Ginseng fermentation system for Ginsenoside increase | |
KR20170061959A (en) | Preparation method of fermented ginseng and fermented black-red ginseng with active ginsenoside heightening rate absorption | |
KR101769184B1 (en) | Preparation for fermented ginseng or red ginseng extract containing increased ginsenoside Rd | |
KR101823585B1 (en) | Methods for preparing fermented ginseng extracts | |
KR101805737B1 (en) | Manufacturing method for fermented Panax ginseng powder and Fermented Panax ginseng powder manufactured by the method | |
KR20130028564A (en) | An extracting method of ginseng by high pressure/enzyme decomposition | |
CN115413779A (en) | Method for accelerating aging of dried orange peel through microbial fermentation | |
KR101372400B1 (en) | A manufacturing method of red ginseng staf4h with enhanced trace ginsenoside | |
KR20160126591A (en) | Method of producing ginseng fermented extract, Ginseng fermented extract produced by the same and Health functional foods comprising the same | |
KR20190079213A (en) | Method manufacture of fermented wild ginseng extract and fermented wild ginseng extract manufactured by the same | |
KR101414741B1 (en) | The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract | |
KR101428682B1 (en) | Functional coffee beverage composition comprising coffee fermented products and extracts thereof and its production method | |
KR20160090936A (en) | A method for manufacturing fermented composition comprising red gingseng and rubus coreanus and the fermented composition by the method | |
KR20160047169A (en) | Composition for reducing methane in ruminants and feed comprising the same | |
KR20180089258A (en) | Its Manufacturing method and Manufacturing for Pill using Moringa(Moringa oleifera) by Fermentation | |
KR101462310B1 (en) | method for lentinula edodes extracts and the extract | |
KR101878430B1 (en) | Process for preparing fermented-red ginseng using aspergillus spp. koji mold | |
KR101683478B1 (en) | Method for producing fermented red ginseng with enhanced ginsenoside Rg3 content | |
CN107595907A (en) | Kefir grain fermented ginseng liquid | |
KR102027035B1 (en) | Composition comprising fermentation product using mushroom for anti-obesity and process for the preparation thereof | |
KR101822425B1 (en) | Method of manufacturing bean yogurt using fermented black garlic | |
KR101749990B1 (en) | Simultaneous two-step fermentation ginseng black vinegar and method for manufacturing the same | |
KR101771075B1 (en) | Composition for improving immune functions comprising extracts of fermented Arctium lappa L.and Spinacia oleracea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |